Showing results (191-200 of 12,921) with videos related to
Sort By:
Pageof 1,293
European Heart Journal|May 15, 2015
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trialJ Steffel, R P Giugliano, E Braunwald, et al.The American Journal of Cardiology|July 13, 2004
Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteriesGraham S Gardner, Daniel R Frisch, Sabina A Murphy, et al.Circulation|May 25, 2011
Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)Willibald Hochholzer, Stephen D Wiviott, Elliott M Antman, et al.Journal of the American College of Cardiology|March 5, 2021
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial FibrillationJan Steffel, Christian T Ruff, Ophelia Yin, et al.Clinical Cardiology|February 4, 1999
Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarctionC P Cannon, E B Johnson, M Cermignani, et al.JAMA|August 21, 2007
Diabetes and mortality following acute coronary syndromesSean M Donahoe, Garrick C Stewart, Carolyn H McCabe, et al.The American Journal of Cardiology|June 21, 2006
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials)Hung Q Ly, Ajay J Kirtane, Sabina A Murphy, et al.Journal of the American College of Cardiology|September 6, 2008
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysisRoberto R Giraldez, Robert P Giugliano, Satishkumar Mohanavelu, et al.The American Journal of Cardiology|August 30, 2005
C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial)Nazanin Moghbeli, Ajay J Kirtane, Kausik K Ray, et al.JAMA|December 27, 2002
Benefit of an early invasive management strategy in women with acute coronary syndromesRuchira Glaser, Howard C Herrmann, Sabina A Murphy, et al.Pageof 1,293